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The role of angiotensin II (Ang II) in the early embryonic development of the heart has not been examined. We have used
RT±PCR to identify mRNA for angiotensinogen, angiotensin-converting enzyme, and the Ang II AT1 and AT2 receptors
in embryonic day 10.25 Sprague±Dawley rats, and have used confocal microscopy to localize the AT1 receptor to the
greater curvature of the developing ventricle in these animals at embryonic days (ED) 9.25 and 10.25. The antibodies used
in immunolocalization studies did not distinguish between the AT1a and AT1b receptor subtypes. In whole embryo culture,
Ang II added to the culture media resulted in increased ventricular growth and myocyte hypertrophy when treated embryos
were compared to cultured littermate controls. Use of Losartan and PD123,319 to block the Ang II AT1 and AT2 receptors
resulted in reduced ventricular development and cardiac dilation when compared to control and Ang II-treated embryos.
Addition of Ang II and PD123,319 to the culture media also resulted in cardiac loop inversions which may be associated
with disruption of normal myo®brillar development. These results clearly indicate an important role for Ang II in the
early embryonic development of the heart. q 1997 Academic Press
INTRODUCTION was inhibited by blocking the function of Ang II. Other in
vivo evidence for the role of Ang II as a growth factor in
The components of the renin-angiotensin system and intact fetal and neonatal hearts is primarily circumstantial.
their roles in adult cardiac hypertrophy have been well doc- These studies have shown changes in the temporal and spa-
umented and reviewed (Baker et al., 1992; Dzau, 1995; tial localization of Ang II receptors or receptor mRNA in
Holtz, 1993; Katz, 1994; Lorell, 1995). In adult hearts, in- various regions of the developing rat heart as embryos in-
creased hemodynamic load results in increased levels of crease in age from ED 11 (Shanmugam et al., 1994a) through
angiotensin II (Ang II) that stimulates signi®cant hypertro- ED 19 (Sechi et al., 1992, 1993; Shanmugam et al., 1994a,b)
phy and remodeling of cardiac structure via increases in and up to 10 days after birth (Sechi et al., 1992, 1993; Shan-
intracellular protein levels and interstitial collagens. These mugam et al., 1994a; Suzuki et al., 1993). No information
remodeling effects of Ang II are receptor mediated and two is available concerning the role of Ang II as a growth factor
primary types of receptors, AT1 and AT2, have been identi- in the early embryonic development of the rat heart prior
®ed (Sechi et al., 1992, 1993; Shanmugam et al., 1994a,b). to ED 11.
Currently, the majority of known effects of Ang II in the Data from experimentation with isolated myocytes and
heart are mediated via subtypes of the AT1 receptor ®broblasts from late fetal and early neonatal hearts also
(Guthrie, 1995; Kohout and Rogers, 1995). support the role of Ang II as a growth factor. Results from
Recent evidence from in vivo studies indicates that Ang these studies pertinent to this report indicate that: (1) Ang
II also acts as a growth factor and has a potential role in II stimulates the hypertrophy of myocytes (Aceto and Baker,
late fetal and neonatal development of the heart. Beinlich 1990; Baker and Aceto, 1990; Sadoshima et al., 1993); (2)
et al. (1993, 1995) found that Ang II is required for the mechanical stress causes the release of Ang II directly from
normal neonatal cardiac development of pigs by blocking cardiac myocytes which acts as an initial mediator of the
the effects of angiotensin-converting enzyme and the Ang stretch induced hypertrophic response of myocytes (Sado-
shima et al., 1993); (3) both the AT1 and AT2 Ang II receptorII AT1 receptor. In these studies, neonatal cardiac growth
572
0012-1606/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID DB 8764 / 6x32$$$$21 12-15-97 05:06:14 dba
573Angiotensin II in Cardiac Development
nate method (Chomczynski and Sacchi, 1987). RT±PCR was per-subtypes are present in the heart and are developmentally
formed with the GeneAmp RNA PCR kit (Perkin-Elmer, Norwalk,regulated (Sechi et al., 1992, 1993; Sadoshima and Izumo,
CT) using 2 mg of total RNA per reaction. Brie¯y, Moloney murine1993a; Suzuki et al., 1993; Kojima et al., 1994; Yamazaki
leukemia virus RT and random primers were used for cDNA syn-et al., 1995); and (4) activation of the AT1 Ang II receptor
thesis from RNA. The cDNA was ampli®ed with AmpliTaq DNAsubtype mediates hypertrophy of cardiac myocytes via acti-
polymerase and primers for the rat aortic vascular smooth muscle
vation of the immediate-early genes c-fos and c-myc, and Ang II type 1 receptor. Speci®c cDNA sequences used are shown
the late response genes for actin and myosin heavy chains in Table 1. Primer Detective software (Clontech, La Jolla, CA) was
(Yamazaki et al., 1993; Sadoshima and Izumo, 1993b; Sado- used to select the Ang II primers. These primers were synthesized
shima et al., 1995). by the Oligonucleotide Synthesis Facility at the University of South
Carolina (Institute for Biological Research Technology, Columbia,Given the above evidence that Ang II is a potential growth
SC). Primers for b-actin (Clontech) were used to test the integrityfactor that may affect cardiac development, we initiated
of the RNA. Thermal cycling was carried out for 30 cycles at 957Cstudies to determine the effects of Ang II on early heart
for 1 min, 607C for 1 min, and 727C for 30 s. Ampli®cation of thedevelopment in the rat embryo. Speci®cally, we have: (1)
appropriate DNA was veri®ed by separation of RT±PCR productsexamined the in vivo expression and distribution of the Ang
on 2% agarose gels along with PCR DNA markers (Promega Corp.,II AT1 receptor subtype from embryonic days (ED) 9.25 and
Madison, WI) for size reference. Gels were stained with 10 mg/
10.25; (2) utilized the whole-embryo culture system to de- ml ethidium bromide and photographed against UV light with a
termine the effects of exogenous Ang II on the rate of myo- Polaroid camera. Controls were included that omitted the reverse
cyte differentiation and heart development; and (3) used transcriptase from the RT reactions to ensure that RNA and not
Losartan and PD123,319, which are speci®c blockers of the contaminating DNA was ampli®ed. RT±PCR in the absence of
reverse transcriptase resulted in no ampli®cation of contaminatingAT1 and AT2 receptor subtypes, respectively, to determine
DNA with any of the primers used in these studies. Treatment oftheir effects on cardiac development in whole-embryo cul-
RNA samples with RNase-free DNase followed by RT±PCR re-ture.
sulted in the ampli®cation of the appropriate products.
MATERIALS AND METHODS Whole Embryo Culture
Methods for whole embryo culture have been published pre-Reagents
viously (Price et al., 1992; Nakagawa et al., 1997) and are similar
Unless noted, reagents for whole-embryo culture, immunocyto- to those originally described by New (1978) and modi®ed by Sadler
chemistry, and RT±PCR analyses were purchased from Sigma et al. (1982). Age and developmentally matched embryos selected
Chemical Co. (St. Louis, MO) and those for electron microscopy for culture were transferred with intact visceral yolk sacs into cul-
were from Polysciences, Inc., (Warrington, PA). ture bottles containing 4.0 ml of rat serum and 1.0 ml of Tyrode's
solution (0.137 M NaCl, 2.7 mM KCl, 3.6 mM NaH2PO4H2O, 27
mM d-glucose, 3.6 mM NaHCO3, 1.36 M CaCl2, 0.5 mM MgCl2,Animals and 0.13 mM streptomycin). For each mother, 2±3 embryos were
designated as controls. The remaining embryos in the litter wereTime-pregnant Sprague±Dawley rats were obtained from Harlan
designated for a treatment group. Ang II was added to the cultureLaboratory (Indianapolis, IN). Day 0 of pregnancy was considered
media at concentrations of 500 pg/ml, 10 ng/ml, or 10 mg/ml, Losar-midnight of the overnight breeding period. Animals were housed
tan was added at concentrations of 1, 10, or 100 mg/ml, andin a facility approved by the American Association for Accredita-
PD123,319 was added at 3, 30, or 300 nM. Control cultures con-tion of Laboratory Animal Care with food and water ad libitum.
tained no Ang II, Losartan, or PD123,319. Following 24 h in culture,All experimental protocols were approved by the University Insti-
the culture medium was replaced with fresh medium containingtutional Animal Care and Use Committee.
Ang II, Losartan, or PD123,319 as described above. After designated
times in culture, embryos were removed, scored by Brown and
Fabro's (1981) morphological scoring system, and prepared for con-RT±PCR
focal and transmission electron microscopy as described below.
To determine at what developmental stage Ang II may be ex-
pressed and play a role in cardiac myocyte development, we per-
formed RT±PCR analyses for angiotensinogen, angiotensin-con- Confocal Scanning Laser and Transmission
verting enzyme, and the AT1 and AT2 receptors using isolated Electron Microscopy
hearts from embryos that had developed for 10.25 days in vivo.
Angiotensinogen, the precursor molecule for Ang II, was used to Embryos allowed to develop in vivo and in culture were rinsed
in Tyrode's solution with 50 mM KCl to relax the heart, preserveddetermine the potential for the presence of Ang II. Since Ang II is
a product of the renin±angiotensinogen cascade, mRNA for Ang II in 2% paraformaldehyde and stained for confocal microscopy (Price
et al., 1996). To visualize general heart morphology, selected em-does not exist. Attempts to isolate cardiac tissue for RT±PCR at
earlier time points in development resulted in the inclusion of bryos (ED 9.25±10) were stained in a 1:20 dilution of rhodamine
phalloidin (Molecular Probes, Eugene, OR) in phosphate-bufferedsome noncardiac tissue.
After the appropriate gestational period, hearts were carefully saline plus 0.02% sodium azide (PBS±A) overnight at 47C. Rhoda-
mine phalloidin is a speci®c stain for f-actin, a primary componentremoved from 10 to 15 embryos and pooled. Total RNA was iso-
lated from the pooled hearts by the one-step guanidinium thiocya- of the developing cardiac contractile apparatus. To facilitate pene-
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8764 / 6x32$$$$22 12-15-97 05:06:14 dba
574 Price et al.
TABLE 1
Sequences Used to Detect mRNA for the Components of the Angiotensin System
Angiotensinogen
Sense 5*-TCTCTGGACTTATCCACTGACC-3* nt 875±896
Antisense 5*-TCACGGAGAAGTTGTTCTGGGC-3* nt 1215±1236
Angiotensin-converting enzyme
Sense 5*-AACCAGATCCTGCTAGACATGG-3* nt 66±87
Antisense 5*-AGATGTTGGACCAAGTCTGTGC-3* nt 498±519
AT1 receptor
Sense 5*-TTCCGAGATGTCAGAACC-3* nt 680±697
Antisense 5*-GCTAGGCTGATTACATGC-3* nt 1247±1264
AT2 receptor
Sense 5*-CATTCTTCAATCTGGCTGTGG-3* nt 3296±3313
Antisense 5*-GGGTGGACTCTTTATACGAG-3* nt 3647±3666
tration of rhodamine phalloidin and imaging of larger hearts, em- on the SDS gels in relation to molecular weight standards. The
relative amounts of MHC and actin in the various treatment groupsbryos older than ED 10 were encased in 13% polyacrylamide gel
using a modi®cation of the procedure described by Hansen and are expressed as a percentage of that present in untreated control
embryos.Dryer (1981). After ®xation, embryos were rinsed in PBS±A and
placed in polyacrylamide gel that was immediately polymerized
with 2% ammonium persulfate. Polyacrylamide gel encased em-
Morphometry and Statistical Analysesbryos were sectioned at 200 mm with an Oxford vibratome and
sections were stained with rhodamine phalloidin. For comparative measurements of treated and control animals,
For labeling of Ang II AT1 receptors, either whole embryos or embryos were photographed at 151 on an Olympus dissecting mi-
acrylamide sections of embryos were incubated in a 1:20 dilution of croscope. Photographic negatives were projected via a Dage MTI
a polyclonal antibody to the AT1 receptors (Chemicon International CCD72 camera to an Image 1 system (Universal Imaging, West
Inc., Temecula, CA) for 24 h at 47C, rinsed in PBS±A, and stained Chester, PA) and measurements of ventricular length and width
overnight at 47C in a 1:50 dilution of FITC. For double labeling, were obtained from the projected image. Ventricular length was
embryos were ®rst labeled for the AT1 receptors followed by rhoda- determined as the distance from the apex to the base of the ventricle
mine phalloidin. Controls consisted of either nonimmune IgG or and ventricular width was measured as the distance across the
PBS buffer substituted for the primary antibody. Antibodies for plane of the ventricle with the greatest diameter (Nakagawa et al.,
the detection of AT2 receptors are not available. All embryos and 1997).
sections were examined using a Bio-Rad MRC 1000 CSLM. To determine changes in cardiac growth associated with a spe-
For TEM, embryos were rinsed in Tyrode's solution with 50 mM ci®c treatment, measurements of ventricular length and width for
KCl and processed as previously described (Price et al., 1996). the control embryos of a litter were made and an average value for
each parameter was obtained. The average value from the control
embryos was then used to compare variations in cardiac growth of
the treated embryos from the same litter. Each treatment groupProtein Accumulation
consisted of embryos from at least three mothers and a minimum
To determine the effects of angiotensin, Losartan, and sample size of six embryos per group. Changes in cardiac growth,
PD123,319 on actin and myosin heavy chain levels in the heart, expressed as a percentage of the control, are presented both as raw,
embryos were cultured for 48 h in the presence of 10 mCi/ml of or actual increases in growth, and as normalized data against the
[35S]methionine. Following culture, embryos were rinsed in ice- overall increase in embryo crown±rump length (Nakagawa et al.,
cold Moscona's saline (136.8 mM NaCl, 28.6 mM KCl, 11.9 mM 1997). Data from all whole embryo culture runs were then pooled
NaHCO3, 9.4 mM glucose, 0.08 mM NaH2PO4, pH 7.4) and the and t tests were performed to determine differences in the means
hearts were removed and transferred to an Eppendorf tube con- of the control and treated populations.
taining ice-cold 10% tricholoracetic acid (TCA). Hearts were centri- To compare the proportions of the control and treated popula-
fuged at 15,000g at 47C for 15 min, rinsed in 10% TCA, and again tions in which cardiac inversions occurred, the method of Sokal
centrifuged. The TCA supernatants were discarded and the precipi- and Rohlf (1969) to test the equality of population percentages was
tated tissue was solubilized in 30 ml of SDS gel loading buffer (62.5 used.
mM Tris±HCl, 5.0% b-mercaptoethanol, 10% glycerol, 8.0% SDS,
pH 6.8) and boiled for 10 min. Samples were stored at 0207C until
analyzed. For analysis, samples were boiled for an additional 5 min RESULTS
and a 5-ml aliquot was removed for scintillation counting. An equal
number of radioactive counts were loaded on a 10% SDS±poly- In Vivo Expression and Localization of the AT1
acrylamide gel and the concentrations of biosynthetically labeled Receptor and Angiotensinogen mRNA
actin and MHC were determined as previously described (Simpson
Using RT±PCR, mRNA for angiotensinogen, angioten-et al., 1996). Bands corresponding to actin (43 kDa) and MHC (206
kDa) were identi®ed by calculating the relative mobility of proteins sin-converting enzyme, and the AT1 and AT2 receptor sub-
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FIG. 1. RT±PCR products showing the expression of mRNA for b-actin used as a control and the AT1 and AT2 receptors, angiotensinogen,
and angiotensin-converting enzyme at in vivo embryonic day 10.25. The expression of these mRNAs from isolated hearts identi®es the
potential for an active angiotensin system in the early embryonic heart.
types was detected from the isolated hearts of ED 10.25 Ang II to the culture media increases at a greater rate than
overall growth of the embryo.animals (Fig. 1). Although it was not possible to isolate
cardiac tissue from animals younger than ED 10.25, local- Since the effects of Ang II on cardiac growth in whole
embryo culture were not as pronounced in the cultures ofization of the AT1 receptor by confocal microscopy was
possible at ED 9.25. In animals at this stage of development, ED 10.25 animals, receptor blocking experiments were car-
ried out only on ED 9.25 animals maintained in culture forAT1 receptor localization was con®ned to the right side of
the heart in the area associated with the initial formation 48 h. Experiments with Losartan, a speci®c blocker for the
AT1 receptor, again resulted in signi®cantly larger heartsof the ventricular loop (Fig. 2A). AT1 receptor localization
continued to be restricted to the greater curvature of the at the three concentrations tested (Figs. 4A and 4B).
Blocking of the AT2 receptors with PD123,319 also resultedventricular loop through ED 10.25 (Fig. 2B) and was subse-
quently found throughout the embryonic heart by ED 11.25 in larger hearts at the highest concentration (300 nM) used
(Figs. 4A and 4B). Combining the highest concentrations of(not shown). At higher magni®cations, AT1 receptor local-
ization was detected in the majority of cardiac cells in both Losartan (100 mg/ml) and PD123,319 (300 nM) also resulted
in a signi®cant increase heart size.the developing myo- and pericardium (Fig. 2C), and when
localized on myocyte membranes the AT1 receptor labeling
pattern was similar to that of sarcomeric banding of devel-
Morphological Assessment of the Effects of Ang II,oping myo®brils (Fig. 2D).
Losartan, and PD123,319 on Cardiac Development
in Whole Embryo Culture
Effects of Ang II, Losartan, and PD123,319 on Myocardial development provides a potential explanation
Ventricular Length and Width in Whole Embryo for the apparent paradox of increased heart size in response
Culture to both the increasing concentrations of available Ang II
and the blocking of the Ang II receptors. Figures 5A±5DThe addition of Ang II to the culture media of embryos
isolated at ED 9.25 and cultured for 48 h signi®cantly in- show rhodamine phalloidin-stained confocal images taken
from a control embryo (A) and embryos treated with 10 mg/creased both the ventricular length and width of treated
hearts at the three concentrations of Ang II used. At ED ml of AngII (B), 100 mM Losartan (C), or 300 nM PD123,319
(D). All images are single optical sections taken from com-10.25 plus 48 h in culture, the actual increases in cardiac
growth were not as pronounced and were signi®cant only parable areas near the caudal portion of the ventricular loop.
The myocardium and developing trabeculae of the Ang II-at the higher concentrations of Ang II that were added to
the culture media (Figs. 3A and 3B). The decrease in the treated embryo showed the greatest intensity of staining
for f-actin, which indicates that the increased ventricularobserved effect of Ang II on cardiac growth as the embryos
increased in age and size may be a result of reduced quanti- length and width may be due to cardiac hypertrophy. Trans-
mission electron micrographs (Figs. 6A and 6B) comparingties of Ang II reaching the heart via diffusion through the
body wall, and the potential for an increased number of myo®brillar development in similar areas of the ventricular
walls of control and Ang II-treated embryos also indicatedavailable Ang II receptors in the body wall and other organs
binding Ang II before it diffuses to the cardiac region. that myo®brillar development was more advanced in Ang
II-treated embryos than in controls. De®nitive sarcomeresTo test if increases in heart growth were simply in re-
sponse to increases in overall body size and development, and well-developed Z-bands were frequently found in the
Ang II-treated embryos, but were rarely observed in controlcardiac growth was normalized against an overall increase
in body size (crown±rump length) in response to Ang II embryos.
Conversely, rhodamine phalloidin staining of the myocar-treatment. The majority of data points tested remained sig-
ni®cant at the P ¡ 0.05 test level (Figs. 3A and 3B). This dium of the Losartan-treated embryo showed that the myo-
cardial wall in many areas was a single myocyte layer thickindicates that cardiac growth in response to the addition of
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8764 / 6x32$$$$23 12-15-97 05:06:14 dba
576 Price et al.
FIG. 2. (A±D) Colocalization of the Ang II AT1 receptor antibody (green) and f-actin (red) in embryonic hearts. Images are stacked
confocal Z-series projected dorsal to ventral which results in the right side of the heart being viewed as the left side of the image. In the
ED 9.25 heart (A), the Ang II AT1 receptor is localized primarily on the right side (arrow) in the region of the presumptive ventricle. This
is also the region in which myo®brillogenesis is ®rst initiated. At ED 10.25 (B), AT1 receptor antibody localization continues to be greatest
along the greater curvature of the developing ventricle (arrow). Receptor localization is also heavy in the developing membranes of the
body wall at both embryonic stages (*). In the area of the greater curvature of the ventricle, the AT1 receptor antibody was localized on
the membranes of a majority of the cells in the developing epi- and myocardium (C), and was closely associated with the Z-bands of the
developing myo®brils (arrows, D). Scale bars, 100 mm for A and B; 25 mm for C and D.
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appeared to be less extensive than in the control and Ang
II-treated embryos (Figs. 5A±5D). This indicates that the
observed increase in ventricular length and width associ-
ated with Losartan and PD123,319 treatment may be a re-
sult of cardiac dilation in response to reduced myo®brillar
tension in the developing heart wall.
Biochemical Assessment of Cardiac Actin and
Myosin Heavy Chain (MHC) Accumulation in
response to Ang II, Losartan, and PD123,319
As expected from the morphological observations, both
actin and MHC levels signi®cantly increased when ED
FIG. 3. (A) Effect of Ang II on ventricular length. (B) Effect of Ang
II on ventricular width. Bars labeled as actual are direct compari-
sons of heart size in experimental versus control embryos. Normal-
ized data are a ratio of the heart size and crown±rump length of
an embryo to account for the overall increase in growth of embryos
in response to Ang II. The addition of Ang II signi®cantly increased
the actual ventricular lengths and widths of hearts at all three
concentrations tested. When normalized against increased body
size, the higher concentrations of 10 ng/ml and 10 mg/ml of Ang II
added to the culture media also increased heart size. For ED 9.25,
sample sizes are 25, 7, 24, and 30 for controls, 500 pg/ml, 10 ng/
ml, and 10 mg/ml, respectively. For ED 10.25, sample sizes are 26,
7, 16, and 25 for the respective test groups. Asterisk indicates hearts
are signi®cantly larger than those of control embryos (P ¡ 0.05).
FIG. 4. (A) Effect of Losartan and PD123,319 on ventricular
length. (B) Effect of Losartan and PD123,319 on ventricular width.
Blocking the Ang II AT1 and AT2 receptors with Losartan andrather than the multilayered walls observed in the control
the highest concentration of PD123,319, respectively, resulted inand Ang II-treated embryos (Figs. 5A±5C). Although dis-
signi®cant increases in the heart size of ED 9.25 embryos culturedtinct myo®brils were present in the developing trabeculae
for an additional 48 h. In contrast to increased cardiac size due to
and myocardial wall, development of f-actin did not appear hypertrophy in the presence of Ang II, blocking the Ang II receptors
to be as extensive in the heart of the Losartan-treated em- increased heart size as a result of cardiac dilation. Sample sizes are
bryo as in the control and Ang II-treated embryos. Although 29, 6, 6, 6, 14, 9, 11, 11 for the respective test groups indicated on
not as distinct, development of f-actin in the trabeculae the X axis. Asterisk indicates signi®cantly different than control
embryos P ¡ 0.05).and myocardial wall of the PD123,319-treated embryo also
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FIG. 5. (A±D) Single optical sections collected with the confocal microscope from the caudal region of the ventricular loop in embryos
allowed to develop 9.25 days in vivo and an additional 48 h in culture and stained for f-actin with rhodamine phalloidin. Developing
myo®brils were found in control embryos (A), and embryos were treated with 100 mg/ml of Ang II (B), 100 mM Losartan (C), and 300 nM
PD123,319 (D). However, actin development appeared to be more extensive in the control (A) and Ang II (B)-treated embryos than in the
embryos treated with Losartan (C) and PD123,319 (D). In addition, the wall of the developing myocardium (arrows) in control (A) and
Ang II (B)-treated embryos consisted of multiple layers of cells, whereas areas of the myocardial wall of the Losartan-treated embryo (C)
were frequently a single myocyte thick (arrow). Scale bar, 25 mm.
10.25 embryos were treated with 10 mg/ml of Ang II for 48 control embryos. This may again be related to the biochemi-
cal assessment utilizing the entire heart, whereas the mor-h in culture (Fig. 7). However, Ang II did not signi®cantly
increase the levels of these contractile proteins in the ED phological assessment of development focused on the spe-
ci®c areas in which the AT1 receptor was found.9.25 embryos cultured for 48 h. This may be a result of the
limited distribution of the Ang II AT1 receptor in the heart
during the initial period of culture (Fig. 2A). The biochemi-
Cardiac Inversions Associated with Angiotensin II,cal assay used included the entire heart and may not have
Losartan, and PD123,319 Treatment in Wholebeen sensitive enough to determine an increase in contrac-
Embryo Culturetile proteins in the limited cardiac region expressing the
AT1 receptor during the initial culture period of ED 9.25 When treated with Ang II and PD123,319, embryos that had
been allowed to develop for 9.25 days in vivo and 48 h inembryos. Treatment of embryos with either 100 mM Losar-
tan or 30 nM PD123,319 resulted in a large degree of vari- culture also exhibited an increased frequency of cardiac inver-
sions in which the ventricular loop developed to the left ratherability between culture runs and levels of actin and MHC
that were not signi®cantly different from those found in than to the right (Fig. 8). No other characteristics of disrupted
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FIG. 6. (A, B) Transmission electron micrographs from similar areas of the developing ventricle of control (A) and Ang II (10 mg/ml)-
treated embryos (B). Embryos were allowed to develop for 9.25 days in vivo followed by 48 h in culture. Myo®brillar development in the
Ang II-treated embryo was more extensive and sarcomere and Z-band organization were more advanced than in control embryos. Scale
bar, 10 mM.
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TABLE 2
The Incidence of Cardiac Inversions in Embryos Allowed to
Develop in Vivo for 9.25 Days Followed by 48 h of Development
in Whole Embryo Culture Increased with the Addition of 10 ng
and 10 mg/ml of Ang II, 100 mM Losartan, and PD123,319
Number of Percentage of
Sample cardiac/tail cardiac
Treatment group size inversions inversions
Controls 55 3/1 5.5
500 pg/ml Ang II 7 0 0
10 ng/ml Ang II 27 8/0 29.6*
10 mg/ml Ang II 36 8/0 22.2*
1 mM Losartan 6 0 0
10 mM Losartan 7 0 0
100 mM Losartan 14 2/0 14.3
3 nM PD123,319 13 3/0 23.1
FIG. 7. Contractile protein accumulation in Ang II-treated em- 30 nM PD123,319 8 3/0 37.5*
bryos. Treatment of ED 10.25 embryos with 10 mg/ml of Ang II in 300 nM PD123,319 8 1/0 12.5
whole embryo culture for 48 h signi®cantly increased (P ¡ 0.05)
the accumulation of both actin and myosin heavy chain in the Note. Treatment with Ang II, Losartan, and PD123,319 did not
heart. Treatment of ED 9.25 embryos with 10 mg/ml of Ang II, 10 affect other aspects of left±right body symmetry as indicated by
mM Losartan, or 300 nM PD123,319, and treatment of ED 10.25 normal development of the tail curvature in embryos that exhibit
embryos with Losartan and PD123,319 did not alter the levels of cardiac loop inversions.
actin or myosin heavy chain when compared to control embryos. * The frequency of cardiac inversions is signi®cantly higher than
that of the control population at the P ¡ 0.05 level.
left±right symmetry in body development, including abnor-
mal tail curvature, were observed in Ang II-treated embryos
(Table 2). Addition of Ang II to the culture media of embryos is present as early as ED 10.25 in the rat, and localization
that were allowed to develop for 10.25 days in vivo and 48 h of the AT1 receptor was observed by confocal microscopy
in culture did not result in the development of cardiac inver- at ED 9.25. Hunt et al. (1995) have previously used autoradi-
sions as looping patterns were established prior to culture. ography to localize Ang II receptors in the myocardium of
ED 14 rats and to identify temporal variations in the densityDISCUSSION
of the receptors through fetal and neonatal development.
In Vivo Expression of the Angiotensinogen System Others (Sechi et al., 1992, 1993; Matsubara et al., 1994;
Components Shanmugam et al., 1994a,b) have also shown temporal and
RT±PCR of isolated hearts indicates that message for the spatial variations in the expression of both the AT1 and
necessary components of a local cardiac angiotensin system AT2 receptor subtypes during late fetal, early neonatal, and
adult development, but did not examine early embryonic
cardiac expression of the receptors. During myocardial de-
velopment, the total density of Ang II receptors peaks dur-
ing neonatal development and subsequently decreases in
the adult (Sechi et al., 1992), although subsequent changes
in receptor density have been noted in cases of ventricular
hypertrophy (Lopez et al., 1994).
Effects of Exogenous Angiotensin II and Speci®c
Receptor Blockers during Cardiac Development
Identi®cation of mRNA for the various components of
the angiotensinogen system and immunolocalization of the
AT1 receptor in the embryonic heart does not indicate that
the system is functional at this early stage in development.
FIG. 8. (A, B) Treatment of ED 9.25 embryos with Ang II fre-
However, modi®cation of cardiac growth patterns, myo®-quently resulted in abnormal cardiac looping patterns in which the
brillogenesis, and accumulation of actin and MHC in re-ventricular loop (arrow) and out¯ow tract looped to the left rather
sponse to the addition of Ang II, Losartan, or PD123,319 inthan to the right. (A) Control embryo showing the normal cardiac
whole embryo culture does imply that the AT1 and AT2looping pattern. (B) Ang II-treated embryo in which the ventricular
looping pattern has been disrupted. receptors are responsive, and that Ang II has the potential
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to play a signi®cant role in the early growth and develop- the normal development of cardiac looping (Brown and
Wolpert, 1990; Beddington, 1996).ment of the embryonic heart. The increase in cardiac inver-
sions in response to either increased levels of Ang II or the Normal myo®brillar differentiation has previously been
identi®ed as a requirement for the development of dextralblocking of the AT2 receptor with PD123,319 also indicates
that a proper balance between Ang II levels and receptor looping patterns in the embryonic heart. Most hypotheses
that attempt to explain cardiac looping involve phenomenafunction is required for normal cardiac morphogenesis.
Studies with isolated cardiac myocytes have also indi- such as right side dominance in development of myocytes
at the base of the heart tube (Itasaki et al., 1989, 1991; Pricecated that the addition of Ang II to the culture media results
in myocyte hypertrophy (Aceto and Baker, 1990; Baker and et al., 1996), speci®c pattern formation of myo®brils and
components of the extracellular matrix in different layersAceto, 1990; Miyata and Haneda, 1994; Sadoshima and
Izumo, 1993a) and an increase in the rate and force of myo- and regions of the myocardium (Manasek, 1981; Manasek
et al., 1984; Shiraishi et al., 1992, 1995; Itasaki et al., 1989,cyte contraction (Abdellatif et al., 1991; Rogers et al., 1989;
Kohout and Rogers, 1995). In isolated cardiac myocytes, the 1991; Price et al., 1996), and mechanical tension on myo-
cytes in the greater curvature of the heart tube as it loopsbinding of Ang II to the AT1 receptors initiates a phospho-
tyrosine cascade that activates protein kinase C and the (Taber et al., 1995). During loop formation, cell number
does not change signi®cantly (Manasek, 1981), but cellsexpression of the immediate early genes c-fos and c-myc,
and the late response genes for actin and myosin (Sadoshima along the greater curvature of the loop ¯atten and increase
their apical surface area, while cells in the lesser curvatureand Izumo, 1993b; Sadoshima et al., 1995; Yamazaki et al.,
1993, 1995a). These studies provide additional evidence that do not undergo this shape change (Manasek et al., 1984).
Concurrent with changes in phenotype, myo®brils in theAng II has the potential to increase the rate of myo®brillo-
genesis as we observed in whole embryo culture, and to convex area of the heart loop develop more rapidly than in
the concave portions of the myocardium (Itasaki et al.,induce cardiac hypertrophy that would result in the in-
creases in the ventricular length and width we observed in 1991; Price et al., 1996).
The right side, or convex area, of the developing heartthese experiments.
Blocking the function of the AT1 receptor by the addition loop is also the region in which the Ang II AT1 receptor is
predominantly found in ED 9.25 and 10.25 hearts. In vitroof Losartan blocks the hypertrophic response of isolated
neonatal cardiac myocytes to Ang II (Sadoshima and Izumo, studies with isolated cardiac myocytes have indicated a di-
rect relationship between mechanical stress and the role1993a; Sadoshima et al., 1995), normal hypertrophy of the
neonatal left ventricle (Beinlich et al., 1993, 1995), and of Ang II in cardiac myocyte hypertrophy (Sadoshima and
Izumo, 1993c; Sadoshima et al., 1993; Yamazaki et al.,pathological hypertrophy of the left ventricle in response
to increases in cardiovascular pressure (Rockman et al., 1995a,b). These studies indicate that mechanical stress
stimulates the secretion of Ang II from cardiac myocytes1994; de Gasparo et al., 1994). Similarly, the addition of
Losartan to the whole embryo culture media resulted in and that Ang II mediates mechanical load-induced cardiac
myocyte hypertrophy. This may, in part, explain the moredecreased ventricular development as indicated by the rela-
tively thin myocardial walls and an apparent reduction in advanced cellular and myo®brillar development in the
greater curvature of the ventricular loop (Manasek et al.,the development of distinct myo®brils in the ventricular
myocardium and trabeculae. A similar, but less pronounced 1981, 1984; Itasaki et al., 1991; Shiraishi et al., 1992, 1995;
Price et al., 1996).effect on ventricular development was observed when the
AT2 receptors were blocked by the addition of PD123,319. However, in previous studies in which myo®brillogenesis
was disrupted by the addition of cytochalasin D crystals at
the right base of the heart, polymerization of actin ®laments
Angiotensin and Cardiac Looping in this area was prevented (Itasaki et al., 1991). This resulted
in myo®brils on the left side of the heart being more ad-Cardiac looping is a complex process that is dependent
on a number of genetic and physical factors that may be vanced than those on the right side, and a 100% occurrence
of cardiac inversions. The concentration of AT1 receptorsaffected by Ang II. It has previously been reported that the
addition of Ang II to the culture media of isolated cardiac on the right side of the heart, and the addition of Ang II
to the culture media, should result in an increased rate of®broblasts increases the autocrine production of trans-
forming growth factor-b1 (TGF-b1) in isolated neonatal car- myo®brillogenesis in this area which is essentially the op-
posite of the results from the studies by Itasaki et al. (1991).diac ®broblasts (Lee et al., 1995; Sharma et al., 1994). Initial
expression of two members of the TGF-b1 subfamily, nodal This apparent inconsistency is dif®cult to explain, but the
disruption of normal myo®brillar patterns in the developingand lefty, is also asymmetric in the early embryo (Collignon
et al., 1996; Meno et al., 1996). Both are transiently found heart is a contributing factor to abnormal cardiac looping.
Whole embryo culture has previously been used to iden-on the left side of the embryo and disruption of nodal expres-
sion results in cardiac positioning defects. The asymmetric tify other factors, including receptor-mediated adrenergic
stimulation, that induces situs inversus and an associateddistribution and possible interactions of these growth fac-
tors with Ang II indicate that subsequent asymmetric high incidence of cardiac inversions (Fujinaga and Baden,
1991a,b). Of particular interest is that both adrenergic andchanges in protein accumulation levels may be critical in
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8764 / 6x32$$$$23 12-15-97 05:06:14 dba
582 Price et al.
Bobik, A., Grinpukel, S., Little, P. J., Grooms, A., and Jackman, G.angiotensin receptors are coupled to G-proteins that, when
(1990). Angiotensin and noradrenalin increase PDGF BB receptorsactivated, induce an increase in intracellular calcium levels
and potentiate PDFG BB stimulated DNA synthesis in vascular(Miyata and Haneda, 1994; Fujinaga et al., 1994; Delisee et
smooth muscle. Biochem. Biophys. Res. Commun. 166, 580±al., 1993). In the studies by Fujinaga et al. (1994), use of
588.nifedipine, an L-type Ca2/ channel blocker, decreased the
Brilla, C. G., Reams, G. P., Maisch, B., and Weber, K. T. (1993).
occurrence of adrenergic-induced situs inversus associated Renin-angiotensin system and myocardial ®brosis in hyperten-
with the intracellular Ca2/ increases. Both the adrenergic sion: regulation of the myocardial collagen matrix. Eur. Heart. J.
a1B and angiotensin AT1 receptors are linked to the phos- 14(Suppl. J), 57±61.
pholipase C pathway (Fujinaga and Baden, 1994; Lokuta et Brown, N. A., and Fabro, S. (1981). Quantitation of rat embryonic
al., 1994) which may indicate that shared pathways exist development in vitro: A morphological scoring system. Teratol-
ogy 24, 65±78.in systems that control development of body symmetry.
Brown, N. A., and Wolpert, L. (1990). The development of handed-In the studies by Fujinaga and Baden (1991b), a high per-
ness in left/right asymmetry. Development 109, 1±9.centage (20±30%) of the control embryos cultured prior to
Burgess, M. L., Carver, W., Terracio, L., Wilson, S. P., Wilson,the early neural plate stage also developed cardiac inver-
M. A., and Borg, T. K. (1994). Integrin-mediated collagen gel con-sions. However, in our cultures and those by Fujinaga and
traction by cardiac ®broblasts. Effects of angiotensin II. Circ. Res.Baden in which culture was started during the early neural 74, 291±298.
plate stage (approximately ED 9.0±9.25), inversions oc- Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA
curred in only 5±6% of the control embryos and 20±40% isolation by acid guanidinium thiocyanate±phenol±chloroform
of the treated embryos. Initiation of culture following the extraction. Anal. Biochem. 162, 156±159.
early neural plate stage did not result in a signi®cant num- Collignon, J., Varlet, I., and Robertson, E. (1996). Relationship be-
ber of cardiac inversions in either study. tween asymmetric nodal expression and the direction of embry-
onic turning. Nature 381, 155±158.The use of rhodamine phalloidin in this study focuses the
de Gasparo, M., Rogg, H., Brink, M., Wang, L., Whitebread, S.,morphological assessment of the effects of Ang II, Losartan,
Bullock, G., and Erne, P. (1994). Angiotensin II receptor subtypesand PD123,319 primarily on myocyte development. Ang II
and cardiac function. Eur. Heart. J. 15(Suppl. D), 98±103.also affects the development and function of cardiac ®bro-
Delisee, C., Schaeffer, P., Cazaubon, C., and Chatelain, P. (1993).blasts (Dostal et al., 1992; Schorb et al., 1993; Sadoshima
Characterization of cardiac angiotensin AT1 receptors by [3H]-and Izumo, 1993a; Sadoshima et al., 1995) and extracellular
SR47436. Eur. J. Pharmacol. 247, 139±144.
matrix components (Burgess et al., 1994; Brilla et al., 1993), Dostal, D. E., Rothblum, K. N., Conrad, K. M., Cooper, G. R., and
and interacts with other growth factors such as PDGF Baker, K. M. (1992). Deterction of angiotensin I and II in cultured
(Bobik et al., 1990; Naftilan et al., 1989), which have im- rat cardiac myocytes and ®broblasts. Am. J. Physiol. 263, C851±
portant roles in normal cardiac differentiation (Leveen et al., C863.
1994; Schatteman et al., 1996). We have recently initiated Dzau, V. J. (1995). Molecular biology of angiotensin II biosynthesis
and receptors. Can. J. Cardiol. 11(Suppl. F), 21F±26F.whole embryo culture studies to further examine these in-
Fujinaga, M., and Baden, J. M. (1991a). Evidence for an adrenergicteractions and their potential role in cardiac differentiation.
mechanism in the control of body asymmetry. Dev. Biol. 143,
203±205.
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